HLA association in aspirin-intolerant asthma : DPB1
0301 as a strong marker in a Korean population
- 24/08/11
Doi : 10.1016/j.jaci.2003.12.012
Jeong Hee Choi, MD a, Kyung Wha Lee, PhD b, Heung Bum Oh, MD, PhD c, Kwan Jeh Lee, PhD d, Yu Jin Suh, MD a, Choon Sik Park, MD, PhD e, Hae-Sim Park, MD, PhD a
a Department of Allergy and Rheumatology, Ajou University Hospital, Suwon, South Korea
b Hallym Institute for Genome Application, Hallym University, Anyang, South Korea
c Department of Laboratory Medicine, University of Ulsan College of Medicine, Seoul, South Korea
d Department of Statistics, Dongguk University, Seoul, South Korea
e Division of Allergy and Respiratory Medicine, Soonchunhyang University Hospital, Bucheon, South Korea
 | This study was supported by a grant of the Korean Health 21 R & D project (01-PJ10-PG6-01GN14-0007). Drs Choi and Lee contributed equally to this work. Reprint requests: Dr Hae-Sim Park, Ajou University, Suwon, Korea. |
© 2004
American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 113 - N° 3
P. 562-564 - mars 2004 Retour au numéro
Article précédent
- Inhibition of effector T lymphocytes mediated through antagonism of IL-4
- Richard Enelow, Dawn F. Baramki, Larry C. Borish
- The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype
- Parviz Ahmad-Nejad, Salima Mrabet-Dahbi, Kristine Breuer, Martina Klotz, Thomas Werfel, Udo Herz, Klaus Heeg, Michael Neumaier, Harald Renz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?